Regulatory collaboration on OTC product launches the theme of this year's CHPA RSQ

WASHINGTON - The Consumer Healthcare Products Association will host its Regulatory, Scientific & Quality Conference next week in Bethesda, Md, featuring more than a dozen education sessions on key regulatory, scientific and quality issues impacting the OTC business. 

 

This year’s conference will focus on "Collaborating for Consumer Healthcare Solutions," including how collaboration between industry and the Food and Drug Administration will foster mutually beneficial relationships that drive better consumer health outcomes.

 

Of particular interest, a panel moderated by Gregory Smith, director, U.S. regulatory and government affairs, healthcare, at RB, will address how Rx-to-OTC switch has become a major lever of innovation and a key driver of growth in the self-care arena. 

 

A separate panel of FDA regulators, moderated by Karen Mahoney, deputy director, Division of Nonprescription Drug Products, Center for Drug Evaluation and Research, for the U.S. Food & Drug Administration, will update industry participants on two regulatory issues affecting OTC medicines available today and tomorrow - combination products and the Nonprescription Safe Use Regulatory Expansion (NSURE) initiative. Presenters from the agency will share status updates on these topics, both of which could shape the types of OTC products available in the future.